This HTML5 document contains 59 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q71009205
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована у квітні 1996 artículu científicu espublizáu n'abril de 1996 wetenschappelijk artikel article scientifique publié en 1996 scientific article published on 01 April 1996 im April 1996 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q71009205-A8F91EAC-678D-43F3-995E-7D6EFE04A813
wdt:P577
1996-04-01T00:00:00Z
p:P407
wds:Q71009205-C63FA696-5BFF-4885-A19E-D1CDDDBD499E
wdt:P407
wd:Q1860
p:P2860
wds:Q71009205-31348C3D-075E-4EAF-9F2E-6BCE0120A5DC wds:Q71009205-719AC71D-EAEE-438C-BDA3-33C349E92EEA wds:Q71009205-7FBC05F0-A46E-4EBB-BC5F-7E6AF039D3DB wds:Q71009205-23528AAE-7797-4A88-AB4A-E35D6252CC50 wds:Q71009205-275ECA58-65BB-4377-A87B-F723AB3EF667
wdt:P2860
wd:Q44728809 wd:Q37308354 wd:Q68954545 wd:Q45181139 wd:Q40846047
p:P2093
wds:Q71009205-9B02478C-AC51-4B77-A51C-ABA901FFC2C3 wds:Q71009205-889422B9-3C09-42F9-A7A9-E79B6A294C31 wds:Q71009205-37698218-28B5-4759-B7FD-EA0215AD0C7A wds:Q71009205-62533516-0E64-4FD4-A24B-631F6B051C6C wds:Q71009205-C9057C17-6BDE-4293-9D40-94CA97BA32FF wds:Q71009205-88E36F63-BD50-44D2-8082-4CADA1A2AFEE
wdt:P2093
J Smith R B Nussenblatt M D de Smet D R Kohler V Stark-Vancs R Wittes
rdfs:label
Intraocular levels of methotrexate after intravenous administration Intraocular levels of methotrexate after intravenous administration
skos:prefLabel
Intraocular levels of methotrexate after intravenous administration Intraocular levels of methotrexate after intravenous administration
schema:name
Intraocular levels of methotrexate after intravenous administration Intraocular levels of methotrexate after intravenous administration
p:P1476
wds:Q71009205-DE87BE0D-0CD3-465D-8753-19C02E955EE5
wdt:P1476
Intraocular levels of methotrexate after intravenous administration
p:P304
wds:Q71009205-103AAF81-7B50-4B4A-963A-839AC1AB0398
wdt:P304
442-444
p:P31
wds:Q71009205-D8DF3942-A197-405C-88D9-201D1E22E6E9
wdt:P31
wd:Q13442814
p:P921
wds:Q71009205-3086FCCF-D2CE-47A1-9ADC-A72BF1765E26
wdt:P921
wd:Q422232
p:P698
wds:Q71009205-F93F7818-EB27-4885-BA7F-4BA2758E2BD7
wdtn:P698
n12:8604740
wdt:P698
8604740
p:P1433
wds:Q71009205-BF134E24-7A49-4019-86C1-BD8BD086F8CA
wdt:P1433
wd:Q4744258
p:P433
wds:Q71009205-9FE5AA7F-A104-4B0C-952C-30AE25C7E91A
p:P478
wds:Q71009205-814D689C-CEC4-4F2A-83B4-85F8499528E2
wdt:P433
4
wdt:P478
121
p:P356
wds:Q71009205-C6B9BF94-FA8B-4224-BE17-6DD89315223E
wdtn:P356
n10:S0002-9394(14)70444-1
wdt:P356
10.1016/S0002-9394(14)70444-1